3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Rectal Neoplasms
11
Glioblastoma
10
Breast Neoplasms
10
Lung Neoplasms
9
Head and Neck Neoplasms
8
Neoplasms
6
Neoplasm Metastasis
6
Brain Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Prostatic Neoplasms
5
Leukemia
4
Gliosarcoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Carcinoma, Merkel Cell
3
Adenocarcinoma Of Esophagus
3
Xerostomia
2
Waldenstrom Macroglobulinemia
2
Small Cell Lung Carcinoma
2
Recurrence
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Interventions
Pemetrexed
8
pembrolizumab
6
Cisplatin
6
LMB-100
3
Carboplatin
3
Radiosurgery
2
Plicamycin
2
Dexamethasone
2
Cryotherapy
2
vandetanib
1
tremelimumab
1
tocilizumab
1
rebastinib
1
pevonedistat
1
perflutren
1
nintedanib
1
iodixanol
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
durvalumab
1
defactinib
1
anetumab ravtansine
1
amatuximab
1
alvocidib
1
aldesleukin
1
Vinorelbine
1
Sulfur Hexafluoride
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mesothelioma
×
Radiation
×
Clear all
NCT01604005
2018-01-29
PIT
The Christie NHS Foundation Trust
Phase 3
Terminated
375 enrolled